当前位置： SCI文献检索 > ACTA OPHTHALMOLOGICA期刊下所有文献 > Systemic use of calcium channel blockers associated with less increase in central retinal thickness after uncomplicated cataract surgery.

Systemic use of calcium channel blockers associated with less increase in central retinal thickness after uncomplicated cataract surgery.

Abstract：

PURPOSE:To examine the role of systemic medication on the risk of pseudophakic cystoid macular edema (PCME) following uneventful cataract surgery. METHODS:A total of 269 eyes undergoing routine cataract surgery. Spectral-domain optical coherence tomography imaging was conducted before surgery and at 28 days. Information about medication of the participants was gathered from The National Archive of Health Information (Kanta), an electronic pharmaceutical database. RESULTS:Systemic medication with angiotensin converting enzyme inhibitor/angiotensin II receptor antagonists (p < 0.001), beta-blockers (β-blockers) (p = 0.002), calcium channel blockers (CCBs) (p < 0.001), nitrates (p =0.021) and lipophilic HMG-CoA reductase inhibitors (statins) (p < 0.001) were more frequently prescribed to diabetic compared with nondiabetic patients. In eyes with steroid monotherapy (N = 135), concomitant systemic medication with β-blockers (12.9 ± 24.0 μm versus 28.6 ± 59.5 μm, p = 0.045), CCBs (12.0 ± 22.1 μm versus 26.3 ± 55.6 μm, p = 0.041) and statins (12.9 ± 22.8 μm versus 30.0 ± 61.9 μm, p = 0.038) attenuated a change in central retinal thickness (CRT) when compared to patients not receiving medication. In multivariable analysis, the use of CCBs remained as an independent protective factor against macular swelling at 28 days (-0.23; 95% CI [-0.43 to -0.04]; p = 0.021), when all systemic medications showing statistical significance were included (i.e. β-blockers, CCBs and statins) together with diabetes status. In eyes with nonsteroidal anti-inflammatory drug (NSAID) monotherapy (N = 67) and steroid and NSAID combination therapy (N = 67), CRT increase was moderate both with and without use of systemic medications. CONCLUSION:Systemic vasoactive medication may be protective against CRT change induced by cataract surgery in eyes at risk of PCME such as those with postoperative steroid monotherapy.

journal_name

Acta Ophthalmol

journal_title

Acta ophthalmologica

authors

Danni R,Taipale C,Holmström EJ,Ilveskoski L,Tuuminen R

doi

10.1111/aos.13911

subject

Has Abstract

pub_date

2019-03-01 00:00:00

pages

178-184

issue

eissn

1755-375X

issn

1755-3768

journal_volume

pub_type

杂志文章

在线工具

Systemic use of calcium channel blockers associated with less increase in central retinal thickness after uncomplicated cataract surgery.